Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, close to analysts’ estimates. Its GAAP loss of $1.97 per share was significantly below analysts’ consensus estimates.
PCB manufacturing company TTM Technologies (NASDAQ:TTMI) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 13.8% year on year to $648.7 million. On top of that, next quarter’s revenue guidance ($670 million at the midpoint) was surprisingly good and 4% above what analysts were expecting. Its non-GAAP profit of $0.50 per share was 26.6% above analysts’ consensus estimates.
Online marketplace eBay (NASDAQ:EBAY) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 1.1% year on year to $2.59 billion. Guidance for next quarter’s revenue was better than expected at $2.63 billion at the midpoint, 0.9% above analysts’ estimates. Its non-GAAP profit of $1.38 per share was 3.2% above analysts’ consensus estimates.
Commercial vehicle retailer Rush Enterprises (NASDAQ:RUSH.A) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.1% year on year to $1.85 billion. Its GAAP profit of $0.73 per share was 1.4% above analysts’ consensus estimates.
Manufacturing equipment and systems provider Advanced Energy (NASDAQ:AEIS) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 23.6% year on year to $404.6 million. On top of that, next quarter’s revenue guidance ($420 million at the midpoint) was surprisingly good and 5.4% above what analysts were expecting. Its non-GAAP profit of $1.23 per share was 16.1% above analysts’ consensus estimates.
Electrical construction and infrastructure services provider MYR Group (NASDAQ:MYRG) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.2% year on year to $833.6 million. Its GAAP profit of $1.45 per share was 23.5% above analysts’ consensus estimates.
American firearm manufacturing company Ruger (NYSE:RGR) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $135.7 million. Its GAAP profit of $0.46 per share increased from $0.40 in the same quarter last year.
Hospitality and casino entertainment company MGM Resorts (NYSE:MGM) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 2.4% year on year to $4.28 billion. Its non-GAAP profit of $0.69 per share was 51.5% above analysts’ consensus estimates.
Dental technology company Align Technology (NASDAQ:ALGN) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.8% year on year to $979.3 million. The company expects next quarter’s revenue to be around $1.06 billion, coming in 0.8% above analysts’ estimates. Its non-GAAP profit of $2.13 per share was 7.1% above analysts’ consensus estimates.
Health and wellness products company Herbalife (NYSE:HLF) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.4% year on year to $1.22 billion. Next quarter’s revenue guidance of $1.26 billion underwhelmed, coming in 0.6% below analysts’ estimates. Its non-GAAP profit of $0.59 per share was 44.9% above analysts’ consensus estimates.
Funeral services company Service International (NYSE:SCI) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 2.8% year on year to $1.07 billion. Its non-GAAP profit of $0.96 per share was 5.7% above analysts’ consensus estimates.
Conveyorized car wash service company Mister Car Wash (NYSE:MCW) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 9.4% year on year to $261.7 million. The company expects the full year’s revenue to be around $1.06 billion, close to analysts’ estimates. Its non-GAAP profit of $0.11 per share was in line with analysts’ consensus estimates.
Hotel franchising company Wyndham (NYSE:WH) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.6% year on year to $316 million. Its non-GAAP profit of $0.86 per share was 5.6% above analysts’ consensus estimates.
Diagnostics company Guardant Health (NASDAQ:GH) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 20.8% year on year to $203.5 million. The company’s full-year revenue guidance of $885 million at the midpoint came in 3.2% above analysts’ estimates. Its non-GAAP loss of $0.49 per share was 17% above analysts’ consensus estimates.
Machine vision technology company Cognex (NASDAQ:CGNX) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.5% year on year to $216 million. On the other hand, next quarter’s revenue guidance of $245 million was less impressive, coming in 1.7% below analysts’ estimates. Its non-GAAP profit of $0.16 per share was 20.4% above analysts’ consensus estimates.
Grocery store chain Sprouts Farmers Market (NASDAQ:SFM) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 18.7% year on year to $2.24 billion. Its non-GAAP profit of $1.81 per share was 16.8% above analysts’ consensus estimates.
Funeral services company Carriage Services (NYSE:CSV) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 3.5% year on year to $107.1 million. On the other hand, the company’s full-year revenue guidance of $405 million at the midpoint came in 0.9% below analysts’ estimates. Its non-GAAP profit of $0.96 per share was 14.3% above analysts’ consensus estimates.
Chicken producer Pilgrim’s Pride (NASDAQ:PPC) fell short of the market’s revenue expectations in Q1 CY2025 as sales rose 2.3% year on year to $4.46 billion. Its non-GAAP profit of $1.31 per share was 2.2% below analysts’ consensus estimates.
Wireless chipmaker Qualcomm (NASDAQ:QCOM) announced better-than-expected revenue in Q1 CY2025, with sales up 16.9% year on year to $10.98 billion. The company expects next quarter’s revenue to be around $10.3 billion, close to analysts’ estimates. Its non-GAAP profit of $2.85 per share was 1.2% above analysts’ consensus estimates.
